Broad Neutralizing Antibodies Against SARS-CoV-2: Current Progress and Engineering Strategies
The high-frequency mutation characteristics of SARS-CoV-2 have posed formidable challenges to the development of vaccines and therapeutic agents. Neutralizing antibodies, which serve as effective tools for prevention and control, have undergone continuous updates and iterations in response to viral...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2026-06-01
|
| Saila: | Viruses |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/1999-4915/18/6/642 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|